SMTL ID : 6fx0.1

Structure-based design of Trifarotene (CD5789), a potent and selective RAR gamma agonist for the treatment of acne

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.90 Å

Oligo State

monomer

Ligands

1 x E9T: 6-[3-(1-adamantyl)-4-oxidanyl-phenyl]naphthalene-2-carboxylic acid(Non-covalent)

E9T.1: 18 residues within 4Å: Chain A: F.201, W.227, F.230, L.233, A.234, C.237, L.268, L.271, M.272, I.275, R.278, F.288, S.289, F.304, G.393, A.397, L.400, I.412 16 PLIP interactions: 16 interactions with chain A Hydrophobic interactions: A:W.227, A:F.230, A:F.230, A:F.230, A:A.234, A:L.271, A:L.271, A:F.288, A:F.288, A:F.304, A:A.397, A:L.400, A:I.412 Hydrogen bonds: A:S.289 Salt bridges: A:R.278 pi-Stacking: A:F.304

1 x PG4: TETRAETHYLENE GLYCOL(Non-functional Binders)

PG4.2: 2 residues within 4Å: Chain A: P.377, L.380 1 PLIP interactions: 1 interactions with chain A Water bridges: A:T.384

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Thoreau, E. et al., Structure-based design of Trifarotene (CD5789), a potent and selective RAR gamma agonist for the treatment of acne. Bioorg. Med. Chem. Lett. (2018)

Release Date

2018-05-23

Peptides

Retinoic acid receptor gamma: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Retinoic acid receptor gamma